Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYCC Cyclacel Pharmaceuticals

未开盘 07-16 16:00:00 EDT

1.75

+0.01

+0.57%

盘后1.75

+0.000.00%

19:56 EDT

最高1.76	最低1.70	成交量5.52万
今开1.75	昨收1.74	日振幅3.45%
总市值256.06万	流通市值201.74万	总股本146.33万
成交额9.60万	换手率4.79%	流通股本115.29万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYCC","market":"US","secType":"STK","nameCN":"Cyclacel Pharmaceuticals","latestPrice":1.7499,"timestamp":1721160000000,"preClose":1.74,"halted":0,"volume":55247,"hourTrading":{"tag":"盘后","latestPrice":1.7499,"preClose":1.7499,"latestTime":"19:56 EDT","volume":181,"amount":310.192,"timestamp":1721174172204},"delay":0,"floatShares":1152879,"shares":1463259,"eps":-20.542479,"marketStatus":"未开盘","marketStatusCode":0,"change":0.0099,"latestTime":"07-16 16:00:00 EDT","open":1.75,"high":1.76,"low":1.7,"amount":96046.3957029,"amplitude":0.034483,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-20.542479,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721203200000},"adr":0,"listingDate":1079413200000,"adjPreClose":1.74,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.7402,"preClose":1.74,"latestTime":"08:44 EDT","volume":588,"amount":1025.2233936,"timestamp":1721133877185},"postHourTrading":{"tag":"盘后","latestPrice":1.7499,"preClose":1.7499,"latestTime":"19:56 EDT","volume":181,"amount":310.192,"timestamp":1721174172204},"volumeRatio":0.712273,"impliedVol":6.1603,"impliedVolPercentile":1},"requestUrl":"/m/hq/s/CYCC/tweets","defaultTab":"tweets","newsList":[{"id":"2451625736","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大涨5.45%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451625736","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451625736?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:02","pubTimestamp":1721052124,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时02分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.45%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Scinai Immunotherapeutics Ltd、Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Scinai Immunotherapeutics Ltd、Artelo Biosciences, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为2451.64%、106.68%、64.46%，振幅较大的相关个股有Aeon Biopharma, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Scinai Immunotherapeutics Ltd，振幅分别为76.07%、74.53%、60.34%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715220204aef9c12f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715220204aef9c12f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2451513385","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 快速上涨5.18%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451513385","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451513385?lang=zh_cn&edition=full","pubTime":"2024-07-13 01:40","pubTimestamp":1720806044,"startTime":"0","endTime":"0","summary":"北京时间2024年07月13日01时40分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.18%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Qualigen Therapeutics, Inc.、Soligenix, Inc.、Xortx Therapeutics Inc.较为活跃，换手率分别为3953.75%、105.11%、99.53%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Xortx Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为147.88%、78.88%、65.30%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713014044941f6b26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713014044941f6b26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2450723750","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 下午盘快速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450723750","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450723750?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:26","pubTimestamp":1720553187,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时26分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.10%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Soligenix, Inc.、Uniqure N.V.、180 Life Sciences Corp.涨幅较大，Soligenix, Inc.、180 Life Sciences Corp.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为13191.85%、3224.16%、364.24%，振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为468.99%、196.29%、134.00%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710032628aef8c21c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710032628aef8c21c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2448915145","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.17%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448915145","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448915145?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:44","pubTimestamp":1719841486,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时44分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速上涨6.17%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Senti Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Senti Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.、Geovax Labs, Inc.较为活跃，换手率分别为134.67%、81.64%、52.57%，振幅较大的相关个股有Senti Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为51.78%、28.78%、28.45%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214446aef76db9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214446aef76db9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2446558296","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌12.65%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446558296","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446558296?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:32","pubTimestamp":1719495125,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时32分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下挫12.65%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Nls Pharmaceutics Ltd.、Effector Therapeutics Inc C/Wts 31/12/2025 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Nls Pharmaceutics Ltd.、Gri Bio, Inc.、Kala Bio, Inc.较为活跃，换手率分别为147.56%、90.39%、58.07%，振幅较大的相关个股有Nls Pharmaceutics Ltd.、冠科美博、Engene Holdings Inc.，振幅分别为19.33%、12.57%、10.75%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721320595de72e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721320595de72e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2446395440","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大涨10.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446395440","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446395440?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:31","pubTimestamp":1719408719,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅上涨10.69%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Anew Medical, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为284.24%、60.34%、60.08%，振幅较大的相关个股有Anew Medical, Inc.、Atossa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为37.85%、20.87%、19.51%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621315995da6d7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621315995da6d7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2446875610","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 临近收盘快速跳水6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446875610","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446875610?lang=zh_cn&edition=full","pubTime":"2024-06-26 03:41","pubTimestamp":1719344473,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日03时41分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅跳水6.76%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为1179.58%、241.39%、182.91%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.，振幅分别为272.73%、77.13%、47.00%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062603411396816b01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062603411396816b01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2445070200","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.71%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445070200","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445070200?lang=zh_cn&edition=full","pubTime":"2024-06-24 22:28","pubTimestamp":1719239290,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日22时28分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.71%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.78%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、阿里拉姆制药、Revelation Biosciences, Inc.涨幅较大，Revelation Biosciences, Inc.、Geovax Labs, Inc.、Effector Therapeutics, Inc.较为活跃，换手率分别为1620.19%、120.41%、63.12%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Revelation Biosciences Inc C/Wts 10/01/2027 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为138.91%、59.54%、51.43%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624222811af8eed9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624222811af8eed9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2445258172","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445258172","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445258172?lang=zh_cn&edition=full","pubTime":"2024-06-21 03:08","pubTimestamp":1718910535,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日03时08分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.30%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Trevena, Inc.较为活跃，换手率分别为437.95%、300.29%、208.39%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Effector Therapeutics Inc C/Wts 31/12/2025 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为1012.78%、66.83%、65.07%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621030855aef5de81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621030855aef5de81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2444843767","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444843767","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444843767?lang=zh_cn&edition=full","pubTime":"2024-06-18 23:31","pubTimestamp":1718724671,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日23时31分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.52%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nls Pharmaceutics Ltd.涨幅较大，Mustang Bio, Inc.、Nls Pharmaceutics Ltd.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为665.27%、586.29%、390.94%，振幅较大的相关个股有Nls Pharmaceutics Ltd.、Mustang Bio, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为103.98%、52.69%、49.60%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618233112aef57b79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618233112aef57b79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2444872193","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.33%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444872193","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444872193?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:19","pubTimestamp":1718633962,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时19分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.33%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Gossamer Bio, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为3969.28%、813.50%、129.18%，振幅较大的相关个股有Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Sellas Life Sciences Group, Inc.，振幅分别为93.85%、42.41%、29.99%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061722192296814a59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061722192296814a59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2442655288","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442655288","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442655288?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:34","pubTimestamp":1718199247,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时34分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.41%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Avidity Biosciences, Inc.、Molecular Partners Ag涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为41.78%、19.73%、4.18%，振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Avidity Biosciences, Inc.，振幅分别为21.10%、20.93%、11.45%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213407af8d2fb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213407af8d2fb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2442782179","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 下午盘大幅跳水7.00%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442782179","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442782179?lang=zh_cn&edition=full","pubTime":"2024-06-11 01:06","pubTimestamp":1718039165,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日01时06分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速跳水7.00%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Clene Inc C/Wts 30/12/2025 、Seres Therapeutics, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为56.94%、43.66%、40.77%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Dermata Therapeutics Inc C/Wts ，振幅分别为142.25%、134.12%、107.32%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611010605af8cc677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611010605af8cc677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2440594269","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 下午盘股价大涨6.90%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440594269","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440594269?lang=zh_cn&edition=full","pubTime":"2024-06-01 03:26","pubTimestamp":1717183571,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日03时26分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速拉升6.90%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Genprex, Inc.、Scisparc Ltd.、Allarity Therapeutics, Inc.较为活跃，换手率分别为133.23%、59.33%、44.84%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Genprex, Inc.，振幅分别为97.32%、62.88%、61.98%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601032611af8b6c0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601032611af8b6c0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2439831195","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.85%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439831195","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439831195?lang=zh_cn&edition=full","pubTime":"2024-05-29 01:25","pubTimestamp":1716917137,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日01时25分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.85%。截至发稿，该股报1.93美元/股，成交量2.0831万股，换手率1.42%，振幅9.76%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.85%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529012538941eaac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529012538941eaac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2437248773","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 临近收盘急速下跌6.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437248773","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437248773?lang=zh_cn&edition=full","pubTime":"2024-05-23 03:55","pubTimestamp":1716407706,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日03时55分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速跳水6.22%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Gt Biopharma, Inc.较为活跃，换手率分别为360.60%、178.61%、59.88%，振幅较大的相关个股有Mustang Bio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Alpha Tau Medical Ltd C/Wts ，振幅分别为61.52%、57.14%、48.75%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523035506861ee637&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523035506861ee637&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2436193396","title":"Cyclacel Pharmaceuticals, Inc.2024财年第一财季实现净利润-2.95百万美元，同比增加49.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436193396","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436193396?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:08","pubTimestamp":1716134916,"startTime":"0","endTime":"0","summary":"3月31日，Cyclacel Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-2.95百万美元，同比增加49.14%；其中营业收入为29000.00美元，每股基本收益为-2.27美元。从资产负债表来看，Cyclacel Pharmaceuticals, Inc.总负债8.37百万美元，其中短期债务0.00美元，资产负债比为0.74，流动比率为0.58。机构评级：截至2024年3月31日，当前有2家机构对Cyclacel Pharmaceuticals, Inc.目标价做出预测，其中目标均价为11.00美元，其中最低目标价为11.00美元，最高目标价为11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520000844877ab257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520000844877ab257&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC"],"gpt_icon":0},{"id":"2435525071","title":"Cyclacel 制药公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435525071","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435525071?lang=zh_cn&edition=full","pubTime":"2024-05-15 05:01","pubTimestamp":1715720518,"startTime":"0","endTime":"0","summary":"   * Cyclacel Pharmaceuticals Inc   报告了截至3月底的季度调整后每股亏损2.27美元，高于去年同期的每股收益7.05美元。两位分析师对该季度的平均预期是每股亏损 4.74 美元。华尔街预期为每股亏损 4.93 至 4.56 美元。* 公司季度亏损 295 万美元。* Cyclacel Pharmaceuticals Inc 本季度股价上涨了 20.4%，今年迄今为止亏损了 4.9%。华尔街对 Cyclacel Pharmaceuticals Inc 的 12 个月目标价中位数为 11.00 美元。本摘要由 LSEG 5 月 14 日 09:01 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CYCC"],"gpt_icon":0},{"id":"2435651628","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘大幅跳水11.42%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435651628","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435651628?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:31","pubTimestamp":1715693478,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速跳水11.42%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Nutriband Inc C/Wts 、Generation Bio Co.、Taysha Gene Therapies, Inc.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为35.02%、7.15%、6.50%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Allogene Therapeutics, Inc.、Taysha Gene Therapies, Inc.，振幅分别为21.54%、12.41%、10.62%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131188768edc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131188768edc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2435037396","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 急速拉升10.57%报2.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435037396","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435037396?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:32","pubTimestamp":1715607135,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时32分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅拉升10.57%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Nutriband Inc C/Wts 、Ac Immune Sa、Tevogen Bio Holdings Inc.涨幅较大，Allarity Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Reneo Pharmaceuticals, Inc.较为活跃，换手率分别为22.68%、15.50%、13.53%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc.、Ac Immune Sa，振幅分别为26.92%、12.19%、10.82%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321321587625f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321321587625f2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cyclacel.com","stockEarnings":[{"period":"1week","weight":0.1589},{"period":"1month","weight":0.0354},{"period":"3month","weight":-0.1072},{"period":"6month","weight":-0.1546},{"period":"1year","weight":-0.7971},{"period":"ytd","weight":-0.3446}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cyclacel Pharmaceuticals, Inc.是一家于1996年成立且处于发展阶段的生物制药公司，致力于用于治疗人类癌症和其它重大疾病的新药和与机体有关的药品的开发和商业化。Cyclacel是细胞周期领域的开拓者，它敢于利用仅适合口服的新药来治疗患者。它的目标是在其一系列商业产品和新药筛选机制发展的基础上成为一家着重于血液学、肿瘤学研究的多元化生物医学公司。作为一家处于发展阶段的企业，该公司所有的努力都贡献于其研究和发展上，指导临床试验，开发和收购新的知识产权，提高资金储备和收益率及训练员工。它的目标是开发和商业化面向细胞周期控制各个阶段和用于治疗癌症及其他重大疾病的小分子药物，尤其是那些医疗缺口很大的领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.006177},{"month":2,"riseRate":0.444444,"avgChangeRate":0.08133},{"month":3,"riseRate":0.388889,"avgChangeRate":-0.059058},{"month":4,"riseRate":0.421053,"avgChangeRate":-0.01166},{"month":5,"riseRate":0.421053,"avgChangeRate":-0.011259},{"month":6,"riseRate":0.157895,"avgChangeRate":-0.101938},{"month":7,"riseRate":0.526316,"avgChangeRate":-0.035147},{"month":8,"riseRate":0.277778,"avgChangeRate":-0.079},{"month":9,"riseRate":0.5,"avgChangeRate":-0.005826},{"month":10,"riseRate":0.333333,"avgChangeRate":0.010843},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.012713},{"month":12,"riseRate":0.5,"avgChangeRate":-0.018954}],"exchange":"NASDAQ","name":"Cyclacel Pharmaceuticals","nameEN":"Cyclacel Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cyclacel Pharmaceuticals,CYCC,Cyclacel Pharmaceuticals股票,Cyclacel Pharmaceuticals股票老虎,Cyclacel Pharmaceuticals股票老虎国际,Cyclacel Pharmaceuticals行情,Cyclacel Pharmaceuticals股票行情,Cyclacel Pharmaceuticals股价,Cyclacel Pharmaceuticals股市,Cyclacel Pharmaceuticals股票价格,Cyclacel Pharmaceuticals股票交易,Cyclacel Pharmaceuticals股票购买,Cyclacel Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}